Idenix to Host Conference Call Discussing Second Quarter 2008 Financial Results

    CAMBRIDGE, Mass., July 17 /EMWNews/ -- Idenix

Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report

its financial results for the second quarter of 2008 on Tuesday, July 29,

2008 before the U.S. financial markets open.



    In conjunction with the issuance of the press release, Idenix

management will host a conference call at 8:30 a.m. ET on Tuesday, July 29,

2008 to discuss the company's financial results for the second quarter of

2008 and provide an update on the company's discovery and development

programs.



    To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475

International and enter passcode 56201724 or to listen to a live audio

webcast of the call, go to "Calendar of Events" in the Idenix Investor

Center at http://www.idenix.com. A replay of the call will also be

available from 11:30 a.m. ET on July 29, 2008 until 11:59 p.m. ET on August

12, 2008. To access the replay, please dial 800-642-1687 U.S./Canada or

706-645-9291 International and enter passcode 56201724. An archived webcast

will also be available for two weeks after the call on the Idenix website.

    About Idenix



    Idenix Pharmaceuticals, Inc., headquartered in Cambridge,

Massachusetts, is a biopharmaceutical company engaged in the discovery and

development of drugs for the treatment of human viral and other infectious

diseases. Idenix's current focus is on the treatment of infections caused

by the hepatitis C virus and HIV. For further information about Idenix,

please refer to http://www.idenix.com.



    Idenix Pharmaceutical Contact:



    Amy Sullivan (617) 995-9901